Press release - 23/03/2026 Aggravated neuroimmune response, delayed wound healing Transcription factor NF-κB in astrocytes critically affects the outcome of traumatic brain injury (TBI) Traumatic brain injuries often lead to complications with long-lasting consequences on memory, concentration and movement control. Detrimental secondary inflammatory reactions at the injured tissue sites are often responsible for this. Researchers from Ulm have now shown that a transcription factor plays a key role in reactions to TBI. When this gene regulator is activated, an elevated neuroimmune response promotes inflammation.https://www.gesundheitsindustrie-bw.de/en/article/press-release/aggravated-neuroimmune-response-delayed-wound-healing-transcription-factor-nf-kb-astrocytes-critically-affects-outcome-traumatic
Press release - 23/03/2026 New findings on the first steps in Protein Synthesis In the earliest phase of creating human proteins, the protein complex NAC performs an essential task by starting the first steps towards folding proteins into their correct three-dimensional structures. This discovery was made by an international research team led by scientists from the Center for Molecular Biology of Heidelberg University. https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-findings-first-steps-protein-synthesis
Press release - 19/03/2026 How old are we really? Ageing is a highly individual process. An international consortium coordinated by researchers in Konstanz has developed a method that uses biomarkers to determine a person's biological age – a valuable tool for research on ageing and the development of new approaches in preventive medicine.https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-old-are-we-really
Press release - 09/03/2026 Early detection contributes to declining breast cancer mortality rates in Europe The introduction of mammography screening programs in Europe has significantly changed breast cancer diagnoses, accompanied by a decline in breast cancer mortality rates. This is shown by the most comprehensive analyses of population-based data on breast cancer in 21 European countries to date, led by the DKFZ. The most striking finding: after the introduction of screening, significantly more early-stage, less advanced tumors were detected.https://www.gesundheitsindustrie-bw.de/en/article/press-release/early-detection-contributes-declining-breast-cancer-mortality-rates-europe
Climate protection is health protection - 26/02/2026 Planetary health: advancing human health in the era of climate change Heatwaves, deteriorating air quality and extreme weather events are reshaping our living conditions. The climate and environmental crisis represent one of the greatest threats to human health. Are we prepared? Adaptation strategies, heat action plans and public education are essential to protecting health in a changing climate.https://www.gesundheitsindustrie-bw.de/en/article/news/planetary-health-advancing-human-health-era-climate-change
Press release - 18/02/2026 Shingles vaccination could slow cognitive decline New findings indicate that a shingles vaccination could not only reduce the risk of cognitive impairment and dementia, but also reduce disease progression among those living with dementia. https://www.gesundheitsindustrie-bw.de/en/article/press-release/shingles-vaccination-could-slow-cognitive-decline
Press release - 13/02/2026 Molecular cause of radiation damage identified A severe side effect of radiation therapy can be debilitating fibrotic skin damage. Scientists at the German Cancer Research Center (DKFZ) have now identified a key factor in the development of this radiation damage. Modulating this factor could potentially prevent this severe adverse effect.https://www.gesundheitsindustrie-bw.de/en/article/press-release/molecular-cause-radiation-damage-identified
Press release - 13/02/2026 How pancreatic cancer prepares tumour environment Possible biomarker for earliest stage of development Even before a tumour in the pancreas becomes discernible, an activated cancer gene actively remodels its future environment and creates an inflammatory and immune-defensive microenvironment in which the carcinoma can grow. The scientists' study opens up new possibilities for developing personalised intervention strategies - before a difficult-to-treat tumour even develops.https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-pancreatic-cancer-prepares-tumour-environment-possible-biomarker-earliest-stage-development
Press release - 22/01/2026 NAKO study confirms link between smoking and depression A research group led by the Central Institute of Mental Health in Mannheim has confirmed for the first time within the German National Cohort an association between cigarette consumption and depression. The findings show that depression occurs more frequently over the lifetime of current and former smokers than among those who have never smoked. https://www.gesundheitsindustrie-bw.de/en/article/press-release/nako-study-confirms-link-between-smoking-and-depression
Press release - 08/01/2026 Award for EMG electrode research How modern medical technology can prevent serious consequences of surgical procedures is demonstrated by a recent internationally recognized scientific publication. The study “Validation of conductive resin as electrode material in neuromonitoring with 3D-printed probes” under the leadership of Drs. Kiese and Bucher was awarded at the ICST Conference in Japan and highlights a medical topic that is crucial for the quality of life of many people. https://www.gesundheitsindustrie-bw.de/en/article/press-release/award-emg-electrode-research
Press release - 16/12/2025 New measures to make EU health sector more innovative, competitive and resilient The European Commission has today proposed an ambitious package of measures to improve the health of EU citizens, while ensuring the long-term resilience and competitiveness of the health sector.https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-measures-make-eu-health-sector-more-innovative-competitive-and-resilient
Press release - 08/12/2025 New mutation catalog facilitates personalized cancer therapy When gene mutations are found in the tumor of cancer patients, it is often unclear whether they promote tumor growth or whether a targeted therapy could be effective. A research team led by the Medical Center - University of Freiburg has now compiled a catalog in which over 11,000 gene variants of a central gene family were examined and evaluated for their role in tumor growth. https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-mutation-catalog-facilitates-personalized-cancer-therapy
Press release - 24/11/2025 Shield against metastases and genetically protected CAR-T cells: Double honor for Mirco Julian Friedrich Physician and cancer researcher Mirco Julian Friedrich from the German Cancer Research Center (DKFZ), the stem cell research institute HI-STEM*, and Heidelberg University Hospital (UKHD) has received two awards for two independent research projects: his novel approach to preventing liver metastases and his research on T cells, which he modifies to better protect them from attacks by natural killer cells. https://www.gesundheitsindustrie-bw.de/en/article/press-release/shield-against-metastases-and-genetically-protected-car-t-cells-double-honor-mirco-julian-friedrich
Dossier - 20/11/2025 Prevention as the key to health Many serious illnesses can be prevented or at least mitigated through healthy lifestyles and early diagnosis. However, effective prevention requires holistic approaches at all levels of healthcare and the reinforcement of individual health literacy.https://www.gesundheitsindustrie-bw.de/en/article/dossier/prevention-key-health
Press release - 17/11/2025 How painkillers can contribute to anemia in cancer patients Researchers from the German Cancer Research Center and the University of Freiburg show how certain painkillers influence the iron metabolism of liver cancer cells and can thus contribute to iron deficiency and anemia in cancer patients.https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-painkillers-can-contribute-anemia-cancer-patients
Press release - 13/11/2025 New Initiative: Light for Public Health Light affects how we sleep, feel, and perform – yet public awareness of its impact remains limited. The Light for Public Health initiative aims to make evidence-based knowledge on light and health both accessible and actionable, thus turning scientific insight into public benefit.https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-initiative-light-public-health
Press release - 07/11/2025 How the biological clock ticks in the female reproductive tract - Breakthrough of the Year Award 2025 for Ângela Gonçalves Endometriosis, menopause, ovarian cancer – still poorly researched and often misdiagnosed. Ângela Gonçalves combines AI, molecular biology, and clinical findings to develop non-invasive tools for early detection, personalized care, and healthier aging. The scientist from the DKFZ-Hector Cancer Institute is the winner of the Falling Walls Foundation's “Breakthrough of the Year 2025” award in the Women's Impact category.https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-biological-clock-ticks-female-reproductive-tract-breakthrough-year-award-2025-angela-goncalves
Press release - 05/11/2025 Panty liners prevent bacterial vaginosis Worldwide, almost one third of women of childbearing age suffer from bacterial vaginosis. Such a disorder of the vaginal flora can cause urogenital infections, abscesses on the ovaries or fallopian tubes or premature births. As part of a BW Sprint project, the DITF have laid the basis for the development of a panty liner that supports the health of the vaginal environment and can prevent bacterial vaginosis.https://www.gesundheitsindustrie-bw.de/en/article/press-release/panty-liners-prevent-bacterial-vaginosis
Press release - 04/11/2025 Brain Tumor Charity supports immunotherapy for childhood brain tumors with 1.5 million pounds sterling Ependymomas, brain tumors that occur particularly in young children, are especially difficult to treat and more than half of the children affected have an increased risk of relapse. As part of an international consortium, the KiTZ, the DKFZ, the MFHD and UKHD have received a grant of 1.5 million pounds sterling (GBP) from the British organization The Brain Tumor Charity to develop a new type of immunotherapy for ependymoma.https://www.gesundheitsindustrie-bw.de/en/article/press-release/brain-tumor-charity-supports-immunotherapy-childhood-brain-tumors-15-million-pounds-sterling
Press release - 29/10/2025 Replacing, reducing and refining animal testing Official launch of integrative 3R Centre at Ulm University Developing replacement methods for animal testing is the main goal of the 3R network. One of three new 3R centres in Baden-Württemberg was launched at Ulm University at the beginning of the year and has now officially started work with a kick-off event. The abbreviation 3R stands for "Replace, Reduce, Refine", i.e. replace and reduce animal testing and improve the conditions for unavoidable animal experiments.https://www.gesundheitsindustrie-bw.de/en/article/press-release/replacing-reducing-and-refining-animal-testing-official-launch-integrative-3r-centre-ulm-university
Press release - 28/10/2025 AI solutions from the DKFZ set new standards in medical image processing Researchers at the German Cancer Research Center (DKFZ) have achieved outstanding success at this year's world-leading forum for medical image processing and computer-assisted intervention. Two DKFZ departments competed in eight international AI competitions – and won seven of them. The successes cover key areas of oncology – from early detection and diagnosis to therapy support and follow-up care.https://www.gesundheitsindustrie-bw.de/en/article/press-release/ai-solutions-dkfz-set-new-standards-medical-image-processing
Press release - 27/10/2025 Role of intestinal bacteria in the development of colorectal cancer: Emmy Noether grant for DKFZ researcher Jens Puschhof The German Research Foundation (DFG) is funding a new Emmy Noether project led by Jens Puschhof from the German Cancer Research Center (DKFZ). With this project, the junior researcher aims to decipher the role of certain intestinal bacteria in the earliest stages of colorectal cancer development and investigate how this process can be halted. The long-term goal is to develop new preventive strategies against colorectal cancer.https://www.gesundheitsindustrie-bw.de/en/article/press-release/role-intestinal-bacteria-development-colorectal-cancer-emmy-noether-grant-dkfz-researcher-jens-puschhof
Press release - 27/10/2025 OnkoAktiv receives Cancer Innovation Award 2025 The nationwide OnkoAktiv network, founded at the National Center for Tumor Diseases (NCT) in Heidelberg, has been awarded the Baden-Württemberg Cancer Innovation Prize 2025. The prize recognizes OnkoAktiv for its pioneering role and groundbreaking contribution to the integration of exercise into oncological care.https://www.gesundheitsindustrie-bw.de/en/article/press-release/onkoaktiv-receives-cancer-innovation-award-2025
Press release - 24/10/2025 Freiburg coordinates national early warning system on animal influenza viruses Federal government awards 3.5 million euros in funding to the collaborative research project FLU-PREP. Researchers are developing methods to identify the pandemic potential of new viruses at an early stage.https://www.gesundheitsindustrie-bw.de/en/article/press-release/freiburg-coordinates-national-early-warning-system-animal-influenza-viruses
Press release - 23/10/2025 Predicting Avian Flu Outbreaks in Europe Using Machine Learning Heidelberg researchers identify local outbreak indicators and develop new regional modeling approach. The highly pathogenic avian influenza virus infection – commonly known as bird flu – primarily affects birds. Mammals, however, are also increasingly infected. This increases the probability that the virus will cross over to humans.https://www.gesundheitsindustrie-bw.de/en/article/press-release/predicting-avian-flu-outbreaks-europe-using-machine-learning